Prof John Martin

Photo

Personal Profile

Name: John Martin Email: j.martin@ucl.ac.uk
Title: Prof Tel: 020 7679 6352
Department: Metabolism & Experi Therapeutics Fax: 020 7679 6379
Position: Professor of Cardiovascular Medicine Address: Centre for Cardiovascular Biology & Medicine, BHF Labora, Division of Medicine, UCL, London, WC1E 6JF
Research Domain: Cardiometabolic Science, Experimental Medicine, Global Health, Neuroscience, Personalised Medicine Web Page: Personal Web Page

Profile

Research Description

Strategically, I am establishing joint research between UCL and Yale University. I am leading Phase III trails in UCL in the use of autologous bone marrow stem cells in the repair of the heart. I am also involved in the design and execution of adenoviral gene therapy in the heart and in the uterine artery.

Research Activities

Cardiovascular Biology and Medicine

Critical Care Medicine

Education Description

I give bedside teachings and lectures to undergraduates, as well as lectures outside the UK.

UCL Collaborators

Dr Mike Grocott; Dr Geoffrey Bellingan; Prof Mark Peters; Prof Donald Peebles; Dr Anna David; Prof Hugh Montgomery; Prof Ian Zachary; Prof Mervyn Singer; Dr Ian Evans; Dr Anthony Mathur; Prof Monty Mythen; Prof Steve Humphries; Prof Aroon Hingorani

External Collaborators

Publications

    2013

    • Carr DJ, Aitken RP, Milne JS, Peebles DM, Martin JF, Zachary IC, Wallace JM, David AL (2013). DNA methylation of somatropic axis genes in relation to postnatal growth and metabolism following Ad.VEGF treatment of growth-restricted sheep fetuses.
    • Westphal M, Ylä-Herttuala S, Martin J, Warnke P, Menei P, Eckland D, Kinley J, Kay R, Ram Z, Group ASPECTS (2013). Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol, 14, 823 - 833. doi:10.1016/S1470-2045(13)70274-2
    • Abramowicz H, Abt I, Adamczyk L, Adamus M, Aggarwal R, Alexa C, Andreev V, Antonelli S, Antonioli P, Antonov A, Arneodo M, Arslan O, Aushev V, Aushev Y, Bachynska O, Baghdasaryan A, Baghdasaryan S, Bamberger A, Barakbaev AN, Barbagli G, Bari G, Barreiro F, Bartel W, Bartosik N, Bartsch D, Basile M, Begzsuren K, Behnke O, Behr J, Behrens U, Bellagamba L, Belousov A, Belov P, Bertolin A, Bhadra S, Bindi M, Blohm C, Bokhonov V, Bondarenko K, Boos EG, Borras K, Boscherini D, Bot D, Boudry V, Bozovic-Jelisavcic I, Bold T, Bruemmer N, Bracinik J, Brandt G, Brinkmann M, Brisson V, Britzger D, Brock I, Brownson E, Brugnera R, Bruni A, Bruni G, Brzozowska B, Bunyatyan A, Bussey PJ, Bylinkin A, Bylsma B, Bystritskaya L, Caldwell A, Campbell AJ, Cantun Avila KB, Capua M, Carlin R, Catterall CD, Ceccopieri F, Cerny K, Chekanov S, Chekelian V, Chwastowski J, Ciborowski J, Ciesielski R, Cifarelli L, Cindolo F, Contin A, Contreras JG, Cooper-Sarkar AM, Coppola N, Corradi M, Corriveau F, Costa M, Cvach J, D'Agostini G, Dainton JB, Dal Corso F, Daum K, Delvax J, Dementiev RK, Derrick M, Devenish RCE, De Pasquale S, De Wolf EA, del Peso J, Diaconu C, Dobre M, Dobur D, Dodonov V, Dolgoshein BA, Dolinska G, Dossanov A, Doyle AT, Drugakov V, Durkin LS, Dusini S, Eckerlin G, Egli S, Eisenberg Y, Elsen E, Ermolov PF, Eskreys A, Fang S, Favart L, Fazio S, Fedotov A, Felst R, Feltesse J, Ferencei J, Ferrando J, Ferrero MI, Figiel J, Fischer D-J, Fleischer M, Fomenko A, Foster B, Gabathuler E, Gach G, Galas A, Gallo E, Garfagnini A, Gayler J, Geiser A, Ghazaryan S, Gialas I, Gizhko A, Gladilin LK, Gladkov D, Glasman C, Glazov A, Goerlich L, Gogitidze N, Gogota O, Golubkov YA, Goettlicher P, Gouzevitch M, Grab C, Grabowska-Bold I, Grebenyuk A, Grebenyuk J, Greenshaw T, Gregor I, Grigorescu G, Grindhammer G, Grzelak G, Gueta O, Guzik M, Gwenlan C, Huettmann A, Haas T, Habib S, Haidt D, Hain W, Hamatsu R, Hart JC, Hartmann H, Hartner G, Henderson RCW, Hennekemper E, Henschel H, Herbst M, Herrera G, Hildebrandt M, Hilger E, Hiller KH, Hladky J, Hochman D, Hoffmann D, Hori R, Horisberger R, Hreus T, Huber F, Ibrahim ZA, Iga Y, Ingbir R, Ishitsuka M, Jacquet M, Jakob H-P, Janssen X, Januschek F, Jones TW, Jonsson L, Juengst M, Jung AW, Jung H, Kadenko I, Kahle B, Kananov S, Kanno T, Kapichine M, Karshon U, Karstens F, Katkov II, Kaur P, Kaur M, Kenyon IR, Keramidas A, Khein LA, Kiesling C, Kim JY, Kisielewska D, Kitamura S, Klanner R, Klein M, Klein U, Kleinwort C, Koetz U, Koffeman E, Kogler R, Kondrashova N, Kononenko O, Kooijman P, Korol I, Korzhavina IA, Kostka P, Kotanski A, Kowalski H, Kraemer M, Kretzschmar J, Krueger K, Kuprash O, Kuze M, Landon MPJ, Lange W, Lastovicka-Medin G, Laycock P, Lebedev A, Lee A, Lendermann V, Levchenko BB, Levonian S, Levy A, Libov V, Limentani S, Ling TY, Lipka K, Lisovyi M, List B, List J, Lobodzinska E, Lobodzinski B, Loehr B, Lohmann W, Lohrmann E, Long KR, Longhin A, Lontkovskyi D, Lopez-Fernandez R, Lubimov V, Lukina OY, Maeda J, Magill S, Makarenko I, Malinovski E, Malka J, Mankel R, Margotti A, Marini G, Martin JF, Martyn H-U, Mastroberardino A, Mattingly MCK, Maxfield SJ, Mehta A, Melzer-Pellmann I-A, Mergelmeyer S, Meyer AB, Meyer H, Meyer J, Miglioranzi S, Mikocki S, Milcewicz-Mika I, Idris FM, Monaco V, Montanari A, Moreau F, Morozov A, Morris JV, Morris JD, Mujkic K, Mueller K, Musgrave B, Nagano K, Namsoo T, Nania R, Naumann T, Newman PR, Niebuhr C, Nigro A, Nikitin D, Ning Y, Nobe T, Notz D, Nowak G, Nowak K, Nowak RJ, Nuncio-Quiroz AE, Oh BY, Okazaki N, Olkiewicz K, Olsson JE, Onishchuk Y, Ozerov D, Pahl P, Palichik V, Pandurovic M, Papageorgiu K, Parenti A, Pascaud C, Patel GD, Paul E, Pawlak JM, Pawlik B, Pelfer PG, Pellegrino A, Perez E, Perlanski W, Perrey H, Petrukhin A, Picuric I, Piotrzkowski K, Pirumov H, Pitzl D, Placakyte R, Plucinski (2013). Combination and QCD analysis of charm production cross section measurements in deep-inelastic ep scattering at HERA. EUROPEAN PHYSICAL JOURNAL C, 73(2), - . doi:10.1140/epjc/s10052-013-2311-3

    2011

    • Mehta V, Abi-Nader KN, Shangaris P, Shaw SWS, Boyd M, Zachary IC, Martin JF, Peebles DM, David AL (2011). The Effects of Local Over-Expression of VEGF-D on the Uterine Arteries and Uterine Artery Endothelial Cells of Pregnant Sheep.
    • Mehta V, Peebles DM, Boyd M, Zachary IC, Martin JF, David AL (2011). Gene Targeting to the Utero-Placental Circulation of Pregnant Guinea Pigs.
    • Carr DJ, Aitken RP, Milne JS, Peebles DM, Martin J, Zachary I, Wallace JM, David AL (2011). Maternal Ad.VEGF gene therapy increases fetal growth in growth-restricted sheep fetuses.
    • Carr DJ, Aitken RP, Milne JS, Peebles DM, Martin JF, Zachary IC, Wallace JM, David AL (2011). Prenatal Ad.VEGF gene therapy - a promising new treatment for fetal growth restriction.
    • Carr DJ, Aitken RP, Milne JS, Peebles DM, Martin JF, Zachary IC, Wallace JM, David AL (2011). Maternal Delivery of Ad.VEGF GeneTherapy Increases Fetal Growth Velocity in an Ovine Paradigm of Fetal Growth Restriction.
    • Carr DJ, Aitken RP, Milne JS, Peebles DM, Martin J, Zachary I, David AL, Wallace JM (2011). Alterations in postnatal growth and metabolism following prenatal treatment of intrauterine growth restriction with Ad.VEGF gene therapy in the sheep.

    2010

    • Junemann-Ramirez M, Lehtolainen P, Yates M, Querol S, Horton R, Gomez SG, Duggleby R, Madrigal A, Martin JF, Zachary I (2010). The role of neuropilin-1 expression in endothelial progenitor cell differentiation.
    • Lovell MJ, Yasin M, Lee KL, Cheung K, Shintani Y, Collino M, Sivarajah A, Leung K-Y, Takahashi K, Kapoor A, Yaqoob MM, Suzuki K, Lythgoe MF, Martin J, Munroe PB, Thiemermann C, Mathur A (2010). Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the P13K/Akt survival pathway. Atherosclerosis, 213, 67 - 76.
    • Mehta V, Abi-Nader K, Buitendyk M, Boyd M, Zachary IC, Martin JF, Peebles DM, David AL (2010). The effects of local over-expression of VEGF on uterine arteries and uterine artery endothelial cells of pregnant sheep.
    • Mehta V, Abi-Nader K, Buitendyk M, Shaw SWS, Boyd M, Zachary IC, Martin JF, Peebles DM, David AL (2010). The Effects of Local Over-Expression of VEGF on the Uterine Arteries and Uterine Artery Endothelial Cells of Pregnant Sheep.

    2009

    • Sanz-Rosa D, Frankel P, Yates M, Albanyan A, Harrison P, Martin JF, Zachary I (2009). NEUROPILIN-1 PLAYS A ROLE IN PLATELET AGGREGATION.
    • Kyrtatos PG, Lehtolainen P, Junemann-Ramirez M, Garcia-Prieto A, Price AN, Martin JF, Gadian DG, Pankhurst QA, Lythgoe MF (2009). Magnetic tagging increases delivery of circulating progenitors in vascular injury.. JACC Cardiovasc Interv, 2(8), 794 - 802. doi:10.1016/j.jcin.2009.05.014
    • Abi Nader KN, Mehta V, Torondel B, Wigley V, Zachary I, Martin J, Boyd M, Tezcan B, Filippi E, Petts G, Rodeck C, Peebles D, David AL (2009). The effect of local over-expression of VEGF on the uterine arteries of pregnant sheep long term.

    2008

    • David AL, Torondel B, Zachary I, Wigley V, Abi Nader K, Mehta V, Buckley SMK, Cook T, Boyd M, Rodeck CH, Martin J, Peebles DM (2008). Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep.. Gene Therapy, 15, 1344 - 1350.
    • Sanz-Rosa D, Piotrowska I, Martin JF, Black JW (2008). Role of beta 2 adrenoceptors in the fibrotic process associated to cardiac hypertrophy in rats. EUROPEAN HEART JOURNAL, 29, 108 - 108.
    • David AL, Torondel B, Zachary I, Wigley V, Nader KA, Mehta V, Buckley SMK, Cook T, Boyd M, Rodeck CH, Martin J, Peebles SM (2008). Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep. Current Gene Therapy: the international journal for in-depth reviews on gene therapy, 19, 1344 - 1350.
    • Sanz-Rosa D, Piotrowska I, Black JW, Martin JF (2008). Role of beta 2 adrenoceptors in the fibrotic process of cardiac hypertrophy induced by isoprenaline in rats.
    • Sanz-Rosa D, Frankel P, Martin JF, Zachary I (2008). Neuropilin-1 plays a role in thrombin induced platelet aggregation. EUROPEAN HEART JOURNAL, 29, 827 - 828.

    2007

    • Santiago FS, Ishii H, Shafi S, Khurana R, Kanellakis P, Bhindi R, Ramirez MJ, Bobik A, Martin JF, Chesterman CN, Zachary IC, Khachigian LM (2007). Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21(WAF1/Cip1) transcription and p21(WAF1/Cip1)-Cdk4-cyclin D1 assembly. CIRC RES, 101(2), 146 - 155. doi:10.1161/CIRCRESAHA.106.145235
    • Martin JF, Yla-Herttuala S, Barker S (2007). VEGF agonists for intimal hyperplasia and delivery device.
    • Steptoe A, Gibson EL, Vounonvirta R, Williams ED, Hamer M, Wardle J, Rycroft JA, Martin JF, Erusalimsky JD (2007). The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis, 193, 277 - 282. doi:10.1016/j.atherosclerosis.2006.08.054
    • Sanz-Rosa D, Junemann-Ramirez M, Cheung K, Lehtolainen P, Lythgoe MF, Martin JF (2007). Increase of CTGF mRNA expression and structural alterations determined with MRI and electron microscopy after angioplasty-induced vascular injury in the rat carotid artery.
    • Montgomery HE, Martin JF, Erusalimsky JD (2007). ACE inhibitors for tissue protection.
    • Sanz-Rosa D, Black JW, Martin JF (2007). Apoptosis and fibrosis in endothelial cells: Role of beta2 adrenoceptors.

    2006

    • Martin JF (2006). Stem cells and the heart: ethics, organization and funding.. Nat Clin Pract Cardiovasc Med, 3 Suppl 1, S136 - S137. doi:10.1038/ncpcardio0445
    • Martin JF (2006). Regulation of arterial intimal hyperplasia by angiogenesis related and unrelated mechanisms.
    • Zachary I, Martin JF, Barnard K (2006). Viewpoint: An explanation for the cardiovascular effects of bevacizumab and rofecoxib?. CIRCULATION, 114(19), 173 - 175.

    2005

    • Brydon L, Edwards S, Jia H, Mohamed-Ali V, Zachary I, Martin JF, Steptoe A (2005). Psychological stress activates interleukin-1β gene expression in human mononuclear cells.. Brain, Behavior, and Immunity, 19(6), 540 - 546.
    • Martin JF, Yla-Herttuala S, Barker S (2005). VEGF agonists for intimal hyperplasia and delivery device.
    • Khurana R, Simons M, Martin JF, and Zachary IC (2005). The Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal. Circulation, 112, 1813 - 1824.
    • Harrison P, Mackie I, Mathur A, Robinson MSC, Hong Y, Erusalimsky JD, Machin SJ, Martin JF (2005). Platelet hyper-function in acute coronary syndromes.. Blood Coagulation and Fibrinolysis, 16, 557 - 562.
    • Martin J (2005). A British and a European collaboration in cardiovascular stem cell research. The Lancet, 365, 2070 - 2071.
    • Monaco C, Mathur A, Martin JF (2005). What causes acute coronary syndromes? Applying Koch's postulates. ATHEROSCLEROSIS, 179(1), 1 - 15. doi:10.1016/j.atherosclerosis.2004.10.022
    • Monaco C, Mathur A, Martin JF (2005). What causes acute coronary syndromes? Applying Koch’s postulates.. Atherosclerosis, 364, 183 - 192.
    • Khurana R, Moons L, Luttun A, Collen D, Martin JF, Carmeliet P, Zachary IC (2005). Placental growth factor (PIGF) promotes atherosclerotic intimal thickening and macrophage accumulation.
    • Khurana R, Moons L, Shafi S, Luttun A, Collen D, Martin JF, Carmeliet P, Zachary IC (2005). Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation.. Circulation, 111(21), 2828 - 2836. doi:10.1161/CIRCULATIONAHA.104.495887
    • Khurana R, Simons M, Martin JF, Zachary IC (2005). Role of angiogenesis in cardiovascular disease - A critical appraisal. CIRCULATION, 112(12), 1813 - 1824. doi:10.1161/CIRCULATIONHA.105.535294

    2004

    • Khurana R, Shafi S, Martin J, Zachary I (2004). Vascular endothelial growth factor gene transfer inhibits neointimal macrophage accumulation in hypercholesterolemic rabbits.. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(6), 1074 - 1080.
    • Martin JF, Bonhoeffer P, Angelini G (2004). Continental doctors take leadership in British medicine.. European Heart Journal, 25, 1568 - 1569.
    • Martin J, Mathur A (2004). Stem cells and repair of the heart. The Lancet, 364, 183 - 192.
    • Khurana R, Zhuang Z, Bhardwaj S, Murakami M, De Muinck E, Yla-Herttuala S, Ferrara N, Martin JF, Zachary I, Simons M (2004). Angiogenesis-dependent and independent phases of intimal hyperplasia.. Circulation, 110(16), 2436 - 2443. doi:10.1161/01.CIR.0000145138.25577.F1
    • Khurana R, Shafi S, Martin JF, Zachary I (2004). Effects of periadventitial vascular endothelial growth factor gene transfer.
    • Khurana R, Moons L, Luttun A, Shafi S, Martin JF, Carmeliet P, Zachary I (2004). Placental growth factor enhances macrophage infiltration and early atherogenesis.

    2003

    • Allart B, Lehtolainen P, Yla-Herttuala S, Martin JF, Selwood D (2003). A stable bis-allyloxycarbonyl biotin aldehyde derivative for biotinylation via reductive alkylation: Application to the synthesis of a biotinylated doxorubicin derivative. Bioconjugate Chemistry, 14, 187 - 194.
    • Cotton JM, Hong Y, Hawe E, Mathur A, Humphries SE, Brown AS, Martin JF, Erusalimsky JD (2003). Rise of circulating thrombopoietin following cardiothoracic surgery is potentiated in patients with coronary atherosclerosis: correlation with a preceding increase in levels of interleukin-6. Thrombosis and Haemostasis, 89(3), 538 - 543.
    • Webb KE, Martin JF, Cotton J, Erusalimsky JD, Humphries SE (2003). The 4830C>A polymorphism within intron 5 affects the pattern of alternative splicing occurring within exon 6 of the thrombopoietin gene. Experimental Hematology, 31(6), 488 - 494.
    • Khurana R, Zhuang ZW, Bhardwaj S, Murakami M, de Muinck E, Zachary I, Yla-Herttuala S, Ferrara N, Martin JF, Simons M (2003). Adventitial angiogenesis drives neointima formation.
    • Bassand JP, Martin J, Ryden L, Simoons M (2003). The need for resources for clinical research: proceedings of a policy conference held at the European Heart House, 27-28 June 2002: executive summary. European Heart Journal, 24(12), 1171 - 1173.

    2002

    • Kaposzta Z, Clifton A, Molloy J, Martin JF, Markus HS (2002). S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty. Circulation, 106(24), 3057 - 3062. doi:10.1161/01.CIR.0000041251.07332.28
    • Cotton JM, Mathur A, Hong Y, Brown AS, Martin JF, Erusalimsky JD (2002). Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery. European Heart Journal, 23(12), 953 - 959.
    • Boyd SR, Zachary I, Chakravarthy U, Allen GJ, Wisdom GB, Cree IA, Martin JF, Hykin PG (2002). Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Archives of Ophthalmology, 120(12), 1644 - 1650.
    • Kaposzta Z, Martin JF, Markus HS (2002). Switching off embolization from symptomatic carotid plaque using S- nitrosoglutathione. Circulation, , - .
    • Lehtolainen P, Taskinen A, Laukkanen J, Airenne KJ, Heino S, Lappalainen M, Ojala K, Marjomaki V, Martin JF, Kulomaa MS, Yla-Herttuala S (2002). Cloning and characterization of Scavidin, a fusion protein for the targeted delivery of biotinylated molecules. Journal of Biological Chemistry, 277(10), 8545 - 8550.

    2001

    • Kaposzta Z, Baskerville PA, Madge D, Fraser S, Martin JF, Markus HS (2001). L-arginine and S-nitrosoglutathione reduce embolization in humans. Circulation, 103(19), 2371 - 2375.
    • Mathur A, Hong Y, Martin J, Erusalimsky J (2001). Megakaryocytic differentiation is accompanied by a reduction in cell migratory potential. British Journal of Haematology, 112(2), 459 - 465.
    • Kaposzta Z, Baskerville PA, Fraser SCA, Madge D, Martin JF, Markus HS (2001). S-nitrosoglutathione, a platelet specific nitric oxide donor, and L-arginine reduced embolisation post-carotid endarterectomy. J NEUROL NEUROSUR PS, 70(2), 270 - 270.
    • Khurana R, Martin JF, Zachary I (2001). Gene therapy for cardiovascular disease: a case for cautious optimism. Hypertension, 38(5), 1210 - 1216.
    • Webb KE, Martin JF, Hamsten A, Eriksson P, Iacoviello L, Gattone M, Donati MB, Di Castelnuovo A, Erusalimsky J, Humphries SE (2001). Polymorphisms in the thrombopoietin gene are associated with risk of myocardial infarction at a young age. Atherosclerosis, 154(3), 703 - 711.
    • Mathur A, Robinson MS, Cotton J, Martin JF, Erusalimsky JD (2001). Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thrombosis and Haemostasis, 85(6), 989 - 994.

    2000

    • Harrison P, Robinson MSC, Mather A, Hong Y, Erusalimsky JD, Martin JF, Machin SJ (2000). Platelet function and turnover in acute coronary syndromes.. BLOOD, 96(11), 256A - 256A.
    • Noula C, Bonzom P, Brown A, Gibbons WA, Martin J, Nicolaou A (2000). 1H-NMR lipid profiles of human blood platelets; links with coronary artery disease. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1487(1), 15 - 23.
    • Zachary I, Mathur A, Yla-Herttuala S, Martin J (2000). Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(6), 1512 - 1520.
    • Laitinen M, Hartikainen J, Hiltunen MO, Eranen J, Kiviniemi M, Narvanen O, Makinen K, Manninen H, Syvanne M, Martin JF, Laakso M, Yla-Herttuala S (2000). Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Human Gene Therapy, 11(2), 263 - 270.
    • Yla-Herttuala S, Martin JF (2000). Cardiovascular gene therapy. The Lancet, 355(9199), 213 - 222.
    • Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE (2000). The ACE gene and muscle performance. Nature, 403(6770), 614 - .
    • Cotton JM, Webb KE, Mathur A, Martin JF, Humphries SE (2000). Impact of the -455G>A promoter polymorphism in the B fibrinogen gene on stimulated fibrinogen production following bypass surgery. Thrombosis and Haemostasis, 84(5), 926 - 927.
    • Verheugt FW, Martin JF, Ryden L (2000). European cardiology: 50 years. The Lancet, 356(9230), 671 - 672.
    • Cotton J, Webb KE, Mathur A, Martin JF, Humphries SE (2000). -455G/A polymorphism of the beta-fibrinogen gene is associated with marked alterations in the fibrinogen response following cardiopulmonary bypass surgery. EUR HEART J, 21, 279 - 279.
    • Ulrich S, Hingorani AD, Martin J, Vallance P (2000). What is the optimal age for starting lipid lowering treatment? A mathematical model. BMJ (Clinical Research Ed.), 320(7242), 1134 - 1140.
    • Martin J (2000). The idea is more important than the experiment. The Lancet, 356, 934 - 937.

    1999

    • Robinson NMK, Zhang HY, Bevan AL, de Belder AJ, Moncada S, Martin J, Archard LC (1999). Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in mice. European Journal of Clinical Investigation, 29, 700 - 707.
    • Boyd SR, Zachary I, Martin JF, Hykin PG (1999). Vascular endothelial growth factor (VEGF), but not placental growth factor, correlates with iris neovascularization in human ischaemic eye disease. J VASC RES, 36(4), 329 - 329.
    • Martin JF, Smith RE, Mathur A (1999). Endogenous mediators and thrombophilia.. Baillieres Best Pract Res Clin Haematol, 12(3), 373 - 386.
    • Ulrich S, Hingorani A, Martin J, Vallance P (1999). Lifetime risk of developing coronary heart disease. The Lancet, 353, 925 - .
    • Servos S, Zachary I, Martin J (1999). VEGF modulates NO production: the basis of a cytoprotective effect?. Cardiovascular Research, 41, 509 - 510.
    • van der Loo B, Martin J (1999). A role for changes in platelet production in the cause of acute coronary syndromes. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 672 - 679.
    • Martin J (1999). Fundamental research rapidly applied. RTD Info, (21), 18 - 19.
    • Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H (1999). Human angiotensin I-converting enzyme gene and endurance performance. Journal of Applied Physiology, 87(4), 1313 - 1316.
    • Ulrich S, Hingorani A, Martin J, Vallance P (1999). What is the optimal age for starting lipid lowering treatment? A mathematical model.. BMJ (Clinical Research Ed.), 320, 1134 - 1140.

    1998

    • Bobik R, Hong Y, Breier G, Martin JF, Erusalimsky JD (1998). Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors. FEBS LETT, 423(1), 10 - 14.
    • Pizzulli L, Yang A, Martin JF, Luderitz B (1998). Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. EUR HEART J, 19(1), 80 - 84.
    • Webb KE, Hamsten A, Eriksson P, Humphries SE, Martin JF (1998). A C -> A polymorphism at position 6390 within intron 6 of the thrombopoietin gene is associated with myocardial infarction in young Swedish men. CIRCULATION, 98(17), 524 - 524.
    • Salas E, Langford EJ, Marrinan MT, Martin JF, Moncada S, de Belder AJ (1998). S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo. HEART, 80(2), 146 - 150.
    • Martin JF, De Caterina R (1998). 'Vas-illation'. EUR HEART J, 19(1), 185 - 185.
    • Molloy J, Martin JF, Baskerville PA, Fraser SC, Markus HS (1998). S-nitrosoglutathione reduces the rate of embolization in humans. CIRCULATION, 98(14), 1372 - 1375.

    1997

    • Laitinen M, Zachary I, Breier G, Pakkanen T, Hakkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, YlaHerttuala S (1997). VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. HUM GENE THER, 8(15), 1737 - 1744.
    • YlaHerttuala S, Laitinen M, Zachary I, Breier G, Pakkanen T, Hakkinen T, Luoma J, Risau W, Soma M, Laakso M, Martin JF (1997). Adventitial gene transfer to rabbit carotid arteries. ATHEROSCLEROSIS, 134(1-2), 109 - 110.
    • Laitinen M, Pakkanen T, Luoma JS, Lehtolainen P, Viita H, Agrawal R, Miyanohara A, Friedmann T, Risau W, Soma M, Martin JF, YlaHerttuala S (1997). Gene transfer into the carotid artery using an adventitial collar comparison of the effectiveness of different gene delivery vehicles. ATHEROSCLEROSIS, 134(1-2), 41 - 41.
    • van der Loo B, Martin JF (1997). Megakaryocytes and platelets in vascular disease.. Baillieres Clin Haematol, 10(1), 109 - 123.
    • Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I (1997). Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Letters, 420, 28 - 32.
    • de Belder A, Robinson N, Richardson P, Martin J, Moncada S (1997). Expression of inducible nitric oxide synthase in human heart failure. Circulation, 95(6), 1672 - 1673.
    • Smith REA, Robinson NMK, McPeake JR, Baylis SA, Charles IG, Heaton ND, Moncada S, Williams R, Martin JF (1997). Induction and role of NO synthase in hypotensive hepatic failure. ARTERIOSCLER THROMB VASC BIOL, 17, 3079 - 3082.
    • van der Loo B, Martin JF (1997). The adventitia, endothelium and atherosclerosis. INT J MICROCIRC, 17, 280 - 288.
    • Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD (1997). Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. ARTERIOSCLER THROMB VASC BIOL, 17(4), 802 - 807.
    • Robinson NMK, Westmore KR, Martin JF, Emson P, Charles IG (1997). Inducible nitric oxide synthase gene transcription and protein activity in the rat heart during endotoxaemia. BIOCHEM BIOPHYS RES COMMUN, 231, 211 - 216.

    1996

    • vanderLoo B, Martin JF (1996). Platelet changes in patients with acute myocardial infarction treated with immediate PTCA. CIRCULATION, 94(11), 3001 - 3001.
    • Laitinen M, Pakkanen T, Luoma J, Laakso M, Breier G, Risau W, Soma M, Martin JF, YlaHerttuala S (1996). Local adventitial VEGF gene transfer reduces neointima formation in rabbit carotid arteries. CIRCULATION, 94(8), 3720 - 3720.

    • Martin JF, Kristensen SD, Mathur A, Grove EL, Choudry FA (). The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes. Nature Review Cardiology, , - .